Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

LAB Standard BioTools Inc

2,57

0,07 (2,80%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Standard BioTools (NASDAQ:LAB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Standard BioTools Charts.

Standard BioTools (NASDAQ:LAB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Standard BioTools Charts.

News Standard BioTools Inc

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 18 Mai 2024 (1 Tag vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 17 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form PREC14A - Preliminary proxy statements, contested solicitations
Freitag 10 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Standard BioTools Reports First Quarter 2024 Financial Results
Mittwoch 8 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
Donnerstag 25 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
Donnerstag 25 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
Montag 8 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
Mittwoch 3 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
Montag 18 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Standard BioTools Inc News-Artikel

BTG PACTUAL UNT

JPMorgan Diversified Ret...

Sugarbud Craft Growers (CE)

Rockmount Capital

Creactives Groups

NLBNPIT1UOU8 20241220 30

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen